From: Prognostic value of long non-coding RNA GHET1 in cancers: a systematic review and meta-analysis
Author | Year | Country | Sample size (n) | Cancer type | Cut-off value | Treatments | Outcomes | HR statistic | NOS |
---|---|---|---|---|---|---|---|---|---|
F. Yang | 2014 | China | 42 | GC | Median | Surgery | CP, OS | Survival curve | 7 |
H. Liu | 2018 | China | 86 | ESCC | Median | Surgery | CP, OS | Survival curve | 8 |
H.F. Liu | 2017 | China | 55 | ESCC | Median | Surgery | CP | NA | 8 |
H.Y. Zhou | 2017 | China | 64 | PADC | NA | Surgery | CP | NA | 8 |
J. Li | 2017 | China | 179 | HCC | NA | Surgery | CP, DFS, OS | Survival curve | 8 |
L. Jin | 2017 | China | 68 | HCC | NA | Surgery | CP, OS | Survival curve | 7 |
L.J. Li | 2014 | China | 80 | BLC | Median | Surgery | OS | Survival curve | 7 |
Q.C. Zhang | 2019 | China | 94 | cervical cancer | Median | NA | CP, OS | Data in paper | 7 |
Q.M. Shen | 2018 | China | 105 | NSCLC | Median | NA | CP, DFS, OS | Survival curve | 7 |
R. Song | 2018 | China | 60 | BC | Median | Surgery | CP, OS | Survival curve | 8 |
W. Yang | 2018 | China | 60 | osteosarcoma | Median | Surgery | CP, OS | Survival curve | 7 |
W.J. Xie | 2019 | China | 40 | RCC | Median ratio | Surgery | CP | NA | 8 |
Y. Xia | 2016 | China | 42 | GC | Median | Surgery | CP | NA | 8 |
Y.P. Zhang1 | 2018 | China | 106 | HCC | Median | Surgery | CP, DFS, OS | Survival curve | 8 |
Y.P. Zhang2 | 2018 | China | 182 | HCC | Median | Surgery | CP, DFS, OS | Data in paper | 9 |
Z.B. Guan | 2018 | China | 52 | NSCLC | Median | Surgery | CP, OS | Data in paper | 8 |